Sixth Street Provides $500MM Senior Secured Credit Facility for Arrowhead
Arrowhead Pharmaceuticals has entered into a strategic financing agreement with Sixth Street for long-term, non-dilutive capital to fund innovation and growth opportunities across Arrowhead’s pipeline of RNAi therapeutics.
August 9, 2024
Arrowhead Pharmaceuticals | Christopher Anzalone | Financing Agreement | Jeff Pootoolal | Michael Reslinski | Senior Secured Credit Facility | Sixth Street
Brianna Wilson